martes, 7 de mayo de 2019

With superstar CEO, new CRISPR company targets heart disease - STAT

With superstar CEO, new CRISPR company targets heart disease - STAT

Daily Recap

With a superstar cardiologist as its CEO, new CRISPR company targets heart disease

By SHARON BEGLEY


VERVE THERAPEUTICS
Superstar cardiologist Dr. Sekar Kathiresan is leaving Massachusetts General Hospital to run Verve, which faces scientific and financial hurdles.

No hay comentarios: